Skip to main content

Table 3 Logistic regression of patient characteristics associated with treatment outcomes in the first 6 months after initiating ART

From: Antiretroviral treatment adherence and its determinants in Sub-Saharan Africa: a prospective study at Yaounde Central Hospital, Cameroon

Characteristics Disappeared (n = 51) Died (n = 28)
  Odds ratio
(95%CI)
P-value Odds ratio
(95%CI)
P-value
Age (years)   0.65   0.23
<30 0.98 (0.45-2.15)   0.39 (0.11-1.35)  
30-49 1   1  
≥ 50 1.55 (0.61-3.96)   0.58 (0.13-2.65)  
Sex   0.09   0.37
Male 1   1  
Female 0.58 (0.31-1.08)   0.68 (0.30-1.55)  
Monthly income (USD)   0.9   0.43
<USD50 1.19 (0.55-2.59)   0.92 (0.32-2.63)  
USD50 - USD125 1   1  
>USD125 1.09 (0.44-2.68)   1.67 (0.57-4.90)  
Education   0.44   0.51
Primary 1   1  
Secondary without bachelor 1.38 (0.67-2.84)   1.71 (0.64-4.58)  
Secondary with bachelor or university 0.79 (0.26-2.39)   1.77 (0.49-6.01)  
Travel time to clinic (hour)   0.47   0.97
<1 1   1  
1-4 1.30 (0.62-2.72)   1.02 (0.39-2.71)  
>4 1.93 (0.65-5.75)   1.22 (0.26-5.77)  
Baseline CD4-cell count (cells/μl)   0.86   0.02
<100 1.06 (0.57-1.97)   2.69 (1.12-6.44)  
≥ 100 1   1  
Clinical stage   <0.001   0.11
CDC stage A 1   1  
CDC stage B 5.72 (1.33-24.70)   2.08 (0.59-7.35)  
CDC stage C 16.9 (3.58-80.30)   4.52 (1.04-19.70)  
ART side-effects at 1 month   0.71   0.638
No side-effects 1   1  
One or more side-effects 1.24 (0.40-3.85)   1.43 (0.30-6.73)  
ART side-effects at 1 month   0.14   0.001
Improving 0.49 (0.19-1.26)   0.11 (0.02-0.52)  
Not improving 1   1  
Disclosure of HIV status   0.22   0.93
Yes 1   1  
No 1.10 (0.95-1.27)   1.01 (0.79-1.29)  
  1. Patients who disappeared (n = 51) or died (n = 28) are compared with patients with complete follow-up or transferred (n = 233). OR were calculated using logistic regression, p-values from the likelihood ratio test.